Table 1. The study population.
Number of serum drug concentration analyses | Number of pregnancies | Number of women | |||
---|---|---|---|---|---|
During pregnancy | First twelve weeks following delivery | At baseline | |||
Escitalopram | 110 | 3 | 161 | 97 | 95 |
Citalopram | 78 | 3 | 80 | 58 | 58 |
Fluoxetine | 53 | 2 | 49 | 43a | 41 |
Sertraline | 56 | 5 | 52 | 37 | 34 |
Venlafaxine | 36 | 1 | 44 | 33a | 33 |
Paroxetine | 29 | 6 | 31 | 20 | 19 |
Fluvoxamine | 5 | 2 | 3 | 3 | 3 |
Total | 367 | 22 | 420 | 290a | 281a,b,c |
a In one pregnancy both fluoxetine and venlafaxine were analyzed (at different times) due to change in medication.
b One woman used paroxetine in one pregnancy and fluoxetine in another.
c Nine women were pregnant twice.